Sign Up
S 5221 New York Senate · 2019 Regular Session

Relates to adding W-18 to the schedule of controlled substances

Summary
Adds W-18(4-chloro-N-[1-[2-(4-nitrophenyl)ethyl] 2piperidinylidene]benzenesulfonamide) to the schedule of controlled substances.
Bill status died 3 of 5 stages cleared
Introduction
Apr 2019
Committee Review
Jan 2020
Senate Passage
Jun 2019
Assembly Passage
Governor
Introduced Apr 16, 2019 Last action Jan 8, 2020
Floor votes · Senate Jun 20, 2019

How they voted

60–1
Passed
Total votes 61
Jun 20, 2019
D Democratic39
38 Yea 1 Nay
97% Yea
R Republican22
22 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
9
Key actions
1
Committee
4
Jan 8, 2020
Senate · Referred to committee
REFERRED TO HEALTH
Jan 8, 2020
Assembly · Failed
DIED IN ASSEMBLY
Jun 20, 2019
Assembly · Referred to committee
REFERRED TO HEALTH
Jun 20, 2019
Senate · Passed
PASSED SENATE
Jun 20, 2019
Senate · Referred to committee
COMMITTEE DISCHARGED AND COMMITTED TO RULES
Apr 16, 2019
Senate · Referred to committee
REFERRED TO HEALTH
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.